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Emerging data reveal that besides degrading proteins tagged with ubiquitin, the proteasome 
plays a more varied and decisive role in cellular regulation than previously imagined. In this 
issue, Hanna et al. (2007) expand our view of the proteasome by showing that under certain 
conditions, proteasome composition can be altered to control ubiquitin homeostasis.In the strictest canonical model of proteasome function, 
the 26S proteasome selectively degrades proteins whose 
fates have been sealed by polyubiquitylation. The 26S pro-
teasome is a 2.4 MDa complex composed of two multisub-
unit subcomplexes: a core protease, termed the 20S pro-
teasome, and a regulatory element, termed PA700 or the 
19S regulatory particle (Pickart and Cohen, 2004). The 20S 
proteasome is a 700 kDa complex composed, in eukaryo-
tes, of two copies of 14 different gene products (α1–α7 and 
β1–β7) arranged in four axially stacked heptameric rings 
(α1–7, β1–7, β1–7, α1–7). The cylindrical structure contains 
two copies of each of three distinct catalytic subunits 
(β1, β2, and β5) whose active sites line a central lumen. 
Substrates reach this proteolytic chamber via 13 Å pores 
formed by the α subunit rings at either end of the cylinder 
(Baumeister et al., 1998). These pores, however, can be 
occluded by peptides from the amino termini of α subunits. 
PA700 mediates proteasome function, in part, by remov-
ing this occlusion and destabilizing the tertiary structure of 
protein substrates necessary for their passage through the 
narrow pores. PA700 is a 20-subunit complex that binds to 
either or both ends of the 20S cylinder, thereby positioning 
PA700 as a gatekeeper for substrate entry to the 20S pro-
teasome. Although there is no crystal structure of PA700, 
its general architecture has been established by biochemi-
cal and imaging experiments (Ferrell et al., 2000). PA700 
includes six distinct AAA-family ATPases (Rpt1–Rpt6) 
arranged in a hexameric ring that abuts axially to the outer 
α rings of the 20S proteasome (Smith and Goldberg, 2006). 
This ATP-dependent interaction promotes opening of 
pores and provides an access portal for substrates. Three 
non-ATPase subunits (Rpn1, 2, and 13) associate with the 
ATPase ring to form a subcomplex termed the “base.” 
The remaining Rpn subunits constitute a separate sub-
complex termed the “lid.” Although the functions of most 
lid subunits are unknown, some display deubiquitylating 
activity, and one (Rpn10/S5a) features ubiquitin interaction 
motif (UIM) domains capable of binding to polyubiquitin. 
PA700 also displays chaperone-like activities for substrate 
destabilization and delivery to the proteolytic chamber. The 
overall process of 26S proteasome-catalyzed proteolysis 
depends on ATP hydrolysis. The exact energy-consuming 
steps in proteolysis remain unclear but are required when 
coupling deubiquitylation with degradation and plausibly could be linked to substrate unfolding, translocation, and 
deubiquitylation (Pickart and Cohen, 2004).
Proteasomes Exist in Multiple Structural Forms
The 26S proteasome, although commonly considered a 
single entity of invariant structure and dedicated function, 
exists as a heterogeneous group of structures with differ-
ent functional features. Moreover, cells can regulate pro-
teasome function in response to changing physiological 
demands both by altering the total number of proteasomes 
(Lecker et al., 2006) and by altering the subunit composi-
tion of proteasomes (Glickman and Raveh, 2005).
The 20S Proteasome Exists in at Least Two Forms
The 20S proteasome exists in at least two distinct forms 
that differ in their catalytic subunits. Higher eukaryotes 
contain two genes for each of the three catalytic subunits. 
Two of these genes (β1i and β5i) are encoded in the major 
histocompatibility locus and, with the third gene (β2i), are 
conditionally expressed and selectively incorporated into 
newly synthesized proteasomes instead of their constitu-
tive counterparts under certain physiological states such 
as enhanced immune function (Baumeister et al., 1998). 
Proteasomes containing inducible catalytic subunits are 
termed “immunoproteasomes” as they participate in 
the production of some MHC class I antigenic peptides. 
Although antigen production also involves nonproteaso-
mal events, immunoproteasomes display altered catalytic 
properties that favor production of certain class I peptides 
(Goldberg et al., 2002). Animals lacking genes for induc-
ible catalytic subunits cannot produce these peptides, 
whereas overexpression of inducible genes enhances 
antigen production. Because class I peptides are derived 
from proteins degraded by a ubiquitin-dependent process, 
such results demonstrate that catalytic features of the 26S 
immunoproteasome represent an important regulatory 
determinant of the antigen production pathway.
Regulatory Complexes Bind to 20S Proteasomes
Most eukaryotic cells contain multiple proteins that bind 
directly to the outer α rings of 20S proteasomes as alter-
natives to PA700, thereby generating structurally different 
proteasome-regulatory complexes (Figure 1) (Schmidt et 
al., 2005). Although most of these proteins have defined 
biochemical effects on proteolytic properties of the pro-
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complexes they form remain largely unknown (Rechsteiner 
and Hill, 2005). Notably, unlike PA700, these alternative 
regulators are not ATPases and do not bind to polyubiqui-
tin chains, suggesting that they may direct the proteasome 
in ubiquitin-independent proteolytic functions. The PA28 
family of proteasome regulators illustrates these features 
particularly well. Mammals (and some other species, but 
not yeast) contain three homologous PA28 genes. PA28α 
and PA28β, are found in the MHC locus adjacent to the 
inducible 20S proteasome genes and are upregulated in 
response to cytokines such as interferon-γ (Rechsteiner 
et al., 2000). PA28α and PA28β proteins assemble into a 
heteromeric complex, whereas PA28γ, whose cellular reg-
ulation is unknown, forms a homoheptamer. Each of these 
ring-shaped complexes binds axially to the outer rings of 
the 20S proteasome and enhances proteasome activity 
by removing the occlusion at the proteasome pores. The 
molecular details of the PA28-proteasome interaction and 
the concomitant activation mechanism have been estab-
lished by extensive biochemical studies and an informa-
tive cocrystal structure of the yeast 20S proteasome with 
a PA28 variant from trypanosomes (Glickman and Raveh, 
2005). The exact relationship of this binding and activation 
mechanism to the corresponding mechanisms for other 
proteasome activators such as PA700 remains to be deter-
mined. Unlike PA700, PA28 enhances only the hydrolysis of 
short peptides and cannot specify the degradation of ubiq-
uitylated proteins. Mice with disrupted PA28α and β genes 
are normal in most respects but have defective production 
of certain MHC class I antigens (Goldberg et al., 2002). The 
exact basis for this effect is unclear but may relate to altered 
catalytic specificity promoted by PA28 such that features 
of class I peptides are favored. Nonimmunological roles for 
PA28α and β also seem likely because of their wide expres-
sion and regulation under many physiological conditions, 
but they are still poorly understood. Mice with a disrupted 
PA28γ gene are smaller in size, and their cells display slower 
proliferation and increased susceptibility to apoptosis. The 
mechanistic basis of these effects is unknown, but the reg-
ulated degradation of at least one protein, steroid receptor 
coactivator-3, is blocked after reduction 
of PA28γ by RNAi (Li et al., 2006). These 
results support the general view that the 
type of regulatory protein associated 
with proteasomes can dictate biological 
outcomes of proteasome action.
Eukaryotes contain other proteins that bind to the outer 
rings of 20S proteasomes instead of PA700. PA200 and its 
yeast homolog, Blm10, contain HEAT repeats and activate 
proteasome hydrolysis of peptide substrates by relieving 
the occlusions at the proteasome’s outer rings (Glickman 
and Raveh, 2005). Many physiological roles for PA200 
have been reported, including DNA repair and response 
to stress, but most have been questioned subsequently. 
In addition, two proline-rich proteins, PI31 and Pr39, inhibit 
proteasome function in vitro by directly blocking 20S pro-
teasome activity and attenuating binding of proteasome 
activators (Rechsteiner and Hill, 2005). The physiological 
functions of these proteins are unclear.
Hybrid Proteasomes Consist of Dissimilar Regulators
Because 20S proteasomes contain two identical outer α 
rings, a given molecule can accept two different regulators 
on opposite rings. Such combinatorial assembly could pro-
duce a large repertoire of proteasome structures featuring 
diverse catalytic properties to meet specific physiological 
demands. Although the cellular existence of proteasomes 
with all permutations of regulator combinations has not 
been established, some of these “hybrid” proteasomes 
display catalytic features that differ from those of their 
counterparts with only one type of regulator. For example, 
proteasomes containing PA700 and PA28 generate a quali-
tatively unique set of peptide products with characteristics 
of class I antigens. This form of proteasome could explain 
how the production of class I antigens can depend on both 
ubiquitin-dependent proteolysis and PA28. The mechanis-
tic and physiological forces that govern the relative compo-
sition of various proteasome-regulator structures remain 
poorly understood but are likely to be highly regulated.
Reversibly Associated Proteins Regulate 
 Proteasome Function
Regardless of their exact modular composition, protea-
some-regulator complexes are usually depicted as defined 
structures containing stoichiometric levels of component 
subunits. However, proteasomes reversibly associate with 
many proteins whose proteasomal content is variable and 
Figure 1. The Dynamic Proteasome
The proteasome is composed of a 20S core and 
a 19S regulatory subunit (PA700). The 20S core 
exists in at least two forms (constitutive and im-
muno), which differ in the composition of the cata-
lytic subunits located on β rings. Many regulatory 
proteins (ATP-independent and ATP-dependent) 
that bind to 20S α rings affect the functions of the 
20S proteasome and determine substrate specifi-
city. PA700 or subcomplexes of it (base or lid) may 
function independently of the 20S proteasome in 
nonproteolytic roles. Other proteins—including 
ubiquitin-conjugating proteins, ubiquitin-chain-
binding proteins, and deubiquitylating proteins—
interact with the proteasome reversibly through 
interactions with proteasome regulators.660 Cell 129, May 18, 2007 ©2007 Elsevier Inc.
often substoichiometric (Schmidt et al., 2005). Several well-
documented examples illustrate how such proteins are 
changing views of proteasome function and  regulation.
A broad class of proteasome-associated proteins 
includes E2 ubiquitin-conjugating enzymes and E3 ubiqui-
tin ligases that select substrates for ubiquitylation, indicat-
ing that substrate ubiquitylation and degradation can be 
physically and functionally coupled. Although molecular 
details of such coupling are largely lacking, it is easy to 
imagine how this arrangement could improve efficiency and 
specificity of degradation. In yeast, disrupted proteasomal 
binding of the ubiquitin ligase Ufd4 impairs proteolysis, 
showing that this interaction is functionally important. The 
ubiquitin ligase activity of Hul5 appears to be stimulated 
when it is bound to the proteasome, and ligase activity is 
closely tied to degradation of its substrates, further high-
lighting a tight relationship between proteasome-depend-
ent ubiquitylation and degradation of substrates.
Many proteasome-associated proteins have functions 
intrinsic to the 26S proteasome, including polyubiquitin 
chain binding, deubiquitylation, and protein unfolding. 
Thus, functions canonically ascribed directly to the 26S 
proteasome might be supplemented by or subcontracted 
to reversibly associated proteins. For example, in yeast, 
deletion of Rpn10, the only well-characterized polyubiqui-
tin-chain-binding subunit of the 26S proteasome, has lit-
tle effect on global cellular protein degradation. Although 
other constituent proteasomal subunits might assume 
this role, proteasomes reversibly associate with multi-
ple polyubiquitin-chain-binding proteins such as Rad23, 
Dsk2, Ddi1, the p97/cdc48Ufp1/Npl4 complex, and p62. These 
proteins contain one or more of the domains capable of 
binding polyubiquitin (e.g., UBA domains) and N-terminal 
Ubl (ubiquitin-like) domains that reversibly bind to Rpn 
subunits of the PA700 base. Such proteins likely serve as 
“shuttles” for delivery of polyubiquitylated proteins to the 
proteasome. Cells lacking Rad23 display impaired degra-
dation of some, but not all proteins, and Rad23 is required 
for 26S proteasome-catalyzed degradation of certain 
polyubiquitylated proteins in biochemically defined in vitro 
systems. In contrast, genetic deletion of both Rpn10 and 
Rad23 greatly impairs global protein degradation. These 
results indicate that cellular proteins are delivered to the 
proteasome by multiple routes, and that individual proteins 
may reach their proteasomal destinations by either dedi-
cated or variable paths (Madura, 2004). The rules that gov-
ern such distinctions are not understood but seem likely to 
represent an important and complex element of proteaso-
mal regulation. For example, some polyubiquitylated pro-
teins may be transferred between several shuttle proteins 
before arriving at their proteasomal destination. The p97/
cdc48Ufp1/Npl4 complex, which is required for proteolysis of 
many polyubiquitylated proteins including those extracted 
from the endoplasmic reticulum, appears to transfer some 
of these proteins to Rad23, which then delivers them to the 
proteasome (Richly et al., 2005).
Deubiquitylation is a second important proteasome 
function supplemented by reversibly associated pro-teins. Removal of polyubiquitin chains from substrates is 
essential for proteolysis of polyubiquitylated proteins, and 
PA700 contains intrinsic deubiquitylation activities for this 
purpose (e.g., Rpn11) (Gutterman and Glickman, 2004). 
However, proteasomal deubiquitylation may be directed 
toward other means. Early work suggested that substrate 
deubiquitylation by Uch37, an intrinsic subunit of mamma-
lian PA700, could also confer an editing function to the pro-
teasome and spare certain proteins from degradation by 
prematurely removing the destruction tag. This mechanism 
further highlights the general notion that the proteasome 
actively participates in determining the fate of substrates 
that reach it. Ubp6 and its mammalian homolog Usp14 are 
deubiquitylating enzymes that bind reversibly to the base 
of the proteasome via their Ubl domains. The deubiquit-
ylation activity of Ubp6/Usp14 is greatly enhanced upon 
proteasome binding and deletion of its Ubl domain mimics 
all features of the null mutant in yeast, showing that Ubp6 
function is likely limited to the proteasome. Recent work 
shows that Ubp6 disassembles Hul5-generated polyubiq-
uitin chains, providing further evidence that proteasome-
associated substrate modifications determine the fate of 
proteins. Remarkably, Ubp6 also appears to regulate gen-
eral aspects of both proteasome and ubiquitin homeosta-
sis. Reduced catalytic function of Ubp6 due to an active 
site mutation or genetic deletion decreases total cellular 
ubiquitin levels as a consequence of increased ubiquitin 
degradation (as opposed to ubiquitin recycling) by the 
proteasome. In this issue of Cell, Finley and colleagues 
significantly expand our view of the functional and regu-
latory relationships among ubiquitin, the proteasome, and 
Ubp6 (Hanna et al., 2007). They show that yeast express 
catalytically inactive Ubp6 at higher levels than wild-type 
Ubp6. Genetic restoration of the otherwise reduced ubiq-
uitin levels in these mutant strains reverts Ubp6 expression 
to normal levels. In contrast, genetic reduction of ubiquitin 
expression increases transcription of Ubp6 and increases 
the fraction of proteasomes associated with the protein, 
perhaps as a compensatory response to increase the sup-
ply of ubiquitin recovered from proteasomal processing. 
Cells that express catalytically inactive Ubp6 also have 
higher total levels of proteasome compared to wild-type 
strains. This effect appears to be mediated by the transcrip-
tion factor Rpn4 and may reflect a response to the surpris-
ing inhibitory action of Ubp6 on proteasome activity. Rpn4 
was originally identified as a putative proteasome subunit 
(hence its nomenclature) but subsequently was shown to 
be a rapidly degraded substrate. Inhibition of proteasome 
function increases Rpn4 content by sparing it from degra-
dation; Rpn4 then acts as general transcription factor for 
proteasomal subunits via interaction with PACE (Protea-
some-Associated Control Element) sequences common to 
proteasome genes (Xie and Varshavsky, 2001). Although 
a close structural homolog of Rpn4 has not been identi-
fied in higher eukaryotes, increased expression of protea-
some subunits is a compensatory response to general 
proteasome inhibition in most cells. Remarkably, Hanna et 
al. (2007) show that Rpn4 is not necessary for increased Cell 129, May 18, 2007 ©2007 Elsevier Inc. 661
Ubp6 levels in response to decreased cellular ubiquitin 
content, suggesting an alternative transcriptional pathway 
for the regulation of ubiquitin levels. Thus, these results dis-
tinguish the general regulation of proteasome levels, “pro-
teasome stress,” from “ubiquitin stress,” which selectively 
alters the proteasome composition; in the latter instance 
the selective assembly of proteasomes for selective tasks 
points to the high level of regulation that can be achieved 
through this adaptable complex. Many unresolved ques-
tions raised by the findings ensure future revelations about 
the important regulatory roles of the proteasome.
Nonproteolytic Functions of the Proteasome
Aside from its role as a protease, the proteasome also 
functions nonproteolytically in a variety of cellular proc-
esses including transcription, DNA repair, and chromatin 
remodeling. Any of the various subfunctions of the protea-
some might be used for nonproteolytic processes, but the 
recurring identification of the ATPase subunits of PA700 as 
mediators of nonproteolytic functions suggests that chap-
erone-like activities form a general basis for these actions. 
Distinguishing nonproteolytic roles from closely inter-
twined mechanisms of proteasome-dependent proteolysis 
embedded in the same processes has been challenging.
Early studies in yeast identified specific Rpt mutant 
alleles as suppressors of a Gal4 transactivator mutant. 
Subsequent studies demonstrated at least two direct and 
genetically distinct nonproteolytic activities of PA700 in 
transcriptional initiation and elongation. The transcription-
dependent localization of PA700 ATPases to Gal promoters 
and the demonstration that stable association of a trans-
activator with the histone acetyltransferase complex SAGA 
is driven by the ATPase activity of PA700 has further sup-
ported a cotransactivator role (Collins and Tansey, 2006).
PA700 also acts nonproteolytically in nucleotide excision 
repair (NER) (Reed and Gillette, 2007). Inhibition of protea-
some-dependent proteolysis has no effect on NER activity 
in vitro, whereas inhibition of the ATPase activity of PA700 
inhibits this activity in a Rad23-dependent manner. The Ubl 
domain of Rad23 is required for normal survival of yeast 
after exposure to UV light. The in vivo NER defect resulting 
from the loss of the Ubl domain of Rad23 is suppressed by 
specific mutations of ATPase subunits of PA700 independ-
ently of proteolysis. The same mutant alleles were originally 
identified as regulators of Gal gene transcription, suggest-
ing a common mechanism of action for the two pathways. 
These results also indicate that reversibly associated pro-
teasomal proteins such as Rad23 can mediate both pro-
teolytic and nonproteolytic roles of the proteasome.
Chromatin remodeling is another nonproteolytic role of 
PA700, with implications for both transcription and DNA 
repair. PA700 ATPases mediate gene silencing at telomeres 
by a mechanism involving regulation of nucleosomal his-
tone modification (Collins and Tansey, 2006). Specifically, 
ATPase subunits of PA700 control histone H3 methylation 
in response to histone H2B ubiquitylation. A global role for 
proteasomal ATPases in modulating chromatin structure is 
consistent with several reports showing widespread distri-662 Cell 129, May 18, 2007 ©2007 Elsevier Inc.bution of proteasomal components associated with chro-
matin. Whereas many of these interactions might result in 
proteolytic functions for the 26S proteasome, differential 
occupancy of PA700 and 20S proteasomal subcomplexes 
on DNA indicate that others represent nonproteolytic func-
tions (Sikder et al., 2006). Moreover, transcription from a 
number of genes is modulated differentially and some-
times in opposing fashion by mutations in PA700 and 20S 
proteasome subunits. Perhaps proteolytic and nonproteo-
lytic processes can be spatially and temporally separated 
by the regulated assembly and disassembly of the protea-
some at specific sites during transcription and DNA repair.
The proteasome, once considered a static garbage dis-
posal unit for cellular waste, now is recognized as a multi-
faceted mediator of many essential cellular processes via 
proteolytic and nonproteolytic mechanisms. The modu-
lar and dynamic composition of the proteasome and its 
multiple regulators allows proteasome subtypes to be 
adapted to a wide array of physiological roles.
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